Carol Gallagher

Carol Gallagher is a highly experienced Board Director with a background in biopharmaceuticals and a Pharm.D. from the University of Kentucky. She has held leadership roles at companies like Calistoga Pharmaceuticals and has invested in various pharmaceutical and health-related startups, showcasing expertise in strategy, drug development, and clinical development. With a career spanning roles at Pfizer, Biogen Idec, and as President and CEO of Calistoga Pharmaceuticals, Carol Gallagher has demonstrated strong leadership in the pharmaceutical industry and a keen eye for investing in promising startups in the healthcare sector. Currently, she serves as an Independent Board Director and Venture Advisor at New Enterprise Associates, focusing on Series A and B investments in pharmaceuticals and health services.